SGLT2 Inhibitors Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results
Conditions:   Chronic Kidney Disease;   Type 2 Diabetes Interventions:   Drug: Finerenone (Kerendia, BAY94-8862);   Drug: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study
Conditions:   Cancer;   Diabetes Mellitus, Type 2;   Interleukin 6;   SGLT2 Inhibitors Intervention:   Diagnostic Test: interleukin 6 Sponsor:   Ministry of Health, Saudi Arabia Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2022 Category: Research Source Type: clinical trials